Eng C - Search Results

1

Molecular classification of parathyroid neoplasia by gene expression profiling.

Morrison C, Farrar W, Kneile J, Williams N, Liu-Stratton Y, Bakaletz A, Aldred MA, Eng C. Morrison C, et al. Among authors: eng c. Am J Pathol. 2004 Aug;165(2):565-76. doi: 10.1016/S0002-9440(10)63321-4. Am J Pathol. 2004. PMID: 15277230 Free PMC article.

2

Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination.

Weber F, Shen L, Aldred MA, Morrison CD, Frilling A, Saji M, Schuppert F, Broelsch CE, Ringel MD, Eng C. Weber F, et al. Among authors: eng c. J Clin Endocrinol Metab. 2005 May;90(5):2512-21. doi: 10.1210/jc.2004-2028. Epub 2005 Feb 15. J Clin Endocrinol Metab. 2005. PMID: 15713710

3

Caveolin-1 and caveolin-2,together with three bone morphogenetic protein-related genes, may encode novel tumor suppressors down-regulated in sporadic follicular thyroid carcinogenesis.

Aldred MA, Ginn-Pease ME, Morrison CD, Popkie AP, Gimm O, Hoang-Vu C, Krause U, Dralle H, Jhiang SM, Plass C, Eng C. Aldred MA, et al. Among authors: eng c. Cancer Res. 2003 Jun 1;63(11):2864-71. Cancer Res. 2003. PMID: 12782592

4

Papillary and follicular thyroid carcinomas show distinctly different microarray expression profiles and can be distinguished by a minimum of five genes.

Aldred MA, Huang Y, Liyanarachchi S, Pellegata NS, Gimm O, Jhiang S, Davuluri RV, de la Chapelle A, Eng C. Aldred MA, et al. Among authors: eng c. J Clin Oncol. 2004 Sep 1;22(17):3531-9. doi: 10.1200/JCO.2004.08.127. J Clin Oncol. 2004. PMID: 15337802

5

Silencing of the maternally imprinted tumor suppressor ARHI contributes to follicular thyroid carcinogenesis.

Weber F, Aldred MA, Morrison CD, Plass C, Frilling A, Broelsch CE, Waite KA, Eng C. Weber F, et al. Among authors: eng c. J Clin Endocrinol Metab. 2005 Feb;90(2):1149-55. doi: 10.1210/jc.2004-1447. Epub 2004 Nov 16. J Clin Endocrinol Metab. 2005. PMID: 15546898

6

Peroxisome proliferator-activated receptor gamma is frequently downregulated in a diversity of sporadic nonmedullary thyroid carcinomas.

Aldred MA, Morrison C, Gimm O, Hoang-Vu C, Krause U, Dralle H, Jhiang S, Eng C. Aldred MA, et al. Among authors: eng c. Oncogene. 2003 May 29;22(22):3412-6. doi: 10.1038/sj.onc.1206400. Oncogene. 2003. PMID: 12776192

7

Variable expression of coxsackie-adenovirus receptor in thyroid tumors: implications for adenoviral gene therapy.

Marsee DK, Vadysirisack DD, Morrison CD, Prasad ML, Eng C, Duh QY, Rauen KA, Kloos RT, Jhiang SM. Marsee DK, et al. Among authors: eng c. Thyroid. 2005 Sep;15(9):977-87. doi: 10.1089/thy.2005.15.977. Thyroid. 2005. PMID: 16187905

8

SNP'ing at nasopharyngeal cancer susceptibility: for whom the bell TOLLs.

Aldred MA, Eng C. Aldred MA, et al. Among authors: eng c. Cancer Biol Ther. 2006 Oct;5(10):1292-3. doi: 10.4161/cbt.5.10.3487. Epub 2006 Oct 24. Cancer Biol Ther. 2006. PMID: 17172806 Free article. No abstract available.

9

Pilot study of rosiglitazone therapy in women with breast cancer: effects of short-term therapy on tumor tissue and serum markers.

Yee LD, Williams N, Wen P, Young DC, Lester J, Johnson MV, Farrar WB, Walker MJ, Povoski SP, Suster S, Eng C. Yee LD, et al. Among authors: eng c. Clin Cancer Res. 2007 Jan 1;13(1):246-52. doi: 10.1158/1078-0432.CCR-06-1947. Clin Cancer Res. 2007. PMID: 17200362

10

BMPR2 mutation in a patient with pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasia.

Rigelsky CM, Jennings C, Lehtonen R, Minai OA, Eng C, Aldred MA. Rigelsky CM, et al. Among authors: eng c. Am J Med Genet A. 2008 Oct 1;146A(19):2551-6. doi: 10.1002/ajmg.a.32468. Am J Med Genet A. 2008. PMID: 18792970

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,914 results

Search Page

Filters